A Preliminary Trial: Double-Blind Comparison of Nefazodone, Bupropion-SR, and Placebo in the Treatment of Cannabis Dependence

REFERENCES

• NIDA, Available at: http://www.nida.nih.gov/ResearchReports/Marijuana/ NIDA Research Reports. Accessed 1 October 2008
   Google Scholar
• Stinson F, Ruan W, Pickering R, Grant B. Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychol Med. 2006; 36: 1447–1460
   PubMed Web of Science ®Google Scholar
• Kalant H. Adverse effects of cannabis on health: An update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry. 2004; 28: 849–863
   PubMed Web of Science ®Google Scholar
• Brook J S, Cohen P, Brook D W. Longitudinal study of co-occurring psychiatric disorders and substance use. J Am Acad Child Adolesc Psychiatry. 1998; 37: 322–330
   PubMed Web of Science ®Google Scholar
• Gruber A J, Pope H G, Hudson J I, Yurgelun-Todd D. Attributes of long-term heavy cannabis users: A case-control study. Psychol Med. 2003; 33: 1415–1422
   PubMed Web of Science ®Google Scholar
• Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: A review. Addiction. 2000; 95: 1621–1630
   PubMed Web of Science ®Google Scholar
• Tashkin D P, Fligiel S, Wu T C, et al. Effects of habitual use of marijuana and/or cocaine on the lung. NIDA Res Monogr. 1990; 99: 63–87
   Google Scholar
• ElSohly M A, Ross S A, Mehmedic Z, Arafat R, Yi B, Banahan B F, III. Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980–1997. J Forensic Sci. 2000; 45: 24–30
   PubMed Web of Science ®Google Scholar
• Compton W M, Pringle B. Services research on adolescent drug treatment. Commentary on “The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials”. J Subst Abuse Treat. 2004; 27: 195–196
   PubMed Web of Science ®Google Scholar
• SAMSHA. National Survey on Drug Use and Health, Available at: http://www.oas.samsha.gov/nsduh.htm Accessed 3 October 2008
   Google Scholar
• MTPRG, Marijuana Treatment Project Research Group (MTPRG). Brief treatments for cannabis dependence: Findings from a randomized multi-site trial. J Consult Clin Psychol. 2004; 72: 455–466
   Google Scholar
• Litt M D, Kadden R M, Stephens R S. The Marijuana Treatment Research Group. Coping and self-efficacy in marijuana treatment: Results from the Marijuana Treatment Project. J Consult Clin Psychol 2005; 73: 1015–1025
   PubMed Web of Science ®Google Scholar
• Stephens R S, Roffman R A, Simpson E E. Treating adult marijuana dependence: A test of the relapse prevention model. J Consult Clin Psychol. 1994; 62: 92–99
   PubMed Web of Science ®Google Scholar
• Stephens R S, Roffman R A, Curtin L. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychol. 2000; 68: 898–908
   PubMed Web of Science ®Google Scholar
• Project MATCH Research group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998; 22: 1300–1311
   PubMed Web of Science ®Google Scholar
• Carroll K M. Relapse prevention as a psychosocial treatment: A review of controlled clinical trials. Exp Clin Psychopharmacol. 1996; 4: 46–54
   Web of Science ®Google Scholar
• Budney A J, Higgins S T, Radonovich K J, Novy P L. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol. 2000; 68: 1051–1061
   PubMed Web of Science ®Google Scholar
• O'Malley S S, Kosten T R. Pharmacotherapy of addictive disorders. Rethinking Substance Abuse: What the Science Shows, and What We Should Do about It., W R Miller, K M Carroll. Guilford Press, New York 2006; 240–256
   Google Scholar
• Cornelius J, Salloum I, Haskett R. Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav. 1999; 24: 111–114
   PubMed Web of Science ®Google Scholar
• McRae A, Budney A, Kathleen K. Treatment of marijuana dependence: A review of the literature. J Subst Abuse Treat. 2003; 24: 369–376
   PubMed Web of Science ®Google Scholar
• Budney A J, Hughes J R. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006; 19: 233–238
   PubMed Web of Science ®Google Scholar
• Budney A J, Hughes J R, Moore B A, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry. 2004; 161: 1967–1977
   PubMed Web of Science ®Google Scholar
• Haney M, Ward A S, Comer S D, Foltin R W, Fischman M W. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl). 1999; 141: 385–394
   PubMed Web of Science ®Google Scholar
• Haney M, Ward A S, Comer S D, Foltin R W, Fischman M W. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl). 1999; 141: 395–404
   PubMed Web of Science ®Google Scholar
• Georgotas A, Zeidenberg P. Observations on the effects of four weeks of heavy marijuana smoking on group interaction and individual behavior. Compr Psychiatry. 1979; 20: 427–432
   PubMed Web of Science ®Google Scholar
• Mendelson J. Marijuana withdrawal syndrome in a woman. Am J Psychiatry. 1984; 141: 1289–1290
   PubMed Web of Science ®Google Scholar
• Glassman A. Psychiatry and cigarettes. Arch Gen Psychiatry. 1998; 55: 692–693
   PubMedGoogle Scholar
• Davidson J, Connor K. Bupropion sustained release: A therapeutic overview. J Clin Psychiatry 1998; 59: 25–31
   PubMed Web of Science ®Google Scholar
• Haney M, Ward A S., Comer S D, Hart C L, Foltin R W, Fischman M W. Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology (Berl). 2001; 155: 171–179
   PubMed Web of Science ®Google Scholar
• Levin F, Evans S, McDowell D, Brooks D, Nunes E. Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder. J Addict Dis 2002; 21: 1–16
   PubMed Web of Science ®Google Scholar
• Solhkhah R, Wilens T, Daly J, Prince J, VanPatten S, Biederman J. Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. J Child Adolesc Psychopharmacol. 2005; 15: 777–786
   PubMed Web of Science ®Google Scholar
• Elkashef A, Rawson R, Anderson A, et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology. 2008; 33: 1162–1170
   PubMed Web of Science ®Google Scholar
• Mooney M E, Sofuoglu M. Bupropion for the treatment of nicotine withdrawal and craving. Expert Rev Neurother. 2006; 6: 965–981
   PubMedGoogle Scholar
• Preskorn S H. Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 1995; 56(Suppl. 6)12–21
   PubMed Web of Science ®Google Scholar
• Thase M E. Treatment of severe depression. J Clin Psychiatry 2000; 61(Suppl. 1)17–25
   PubMed Web of Science ®Google Scholar
• Haney M, Hart C L, Ward A S, Foltin R W. Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology (Berl). 2003; 165: 157–165
   PubMed Web of Science ®Google Scholar
• Passos S, Camacho L, Lopes C, dos Santos M. Nefazodone in out-patient treatment of inhaled cocaine dependence: A randomized double-blind placebo-controlled trial. Addiction. 2005; 100: 489–494
   Google Scholar
• Ciraulo D, Knapp C, Rotrosen J, et al. Nefazodone treatment of cocaine-dependence with comorbid depressive symptoms. Addiction. 2005; 100(Suppl.)23–31
   Google Scholar
• Levin F R, McDowell D, Evans S M, et al. Pharmacotherapy for marijuana dependence: A double-blind, placebo-controlled pilot study of divalproex sodium. Am J Addict. 2004; 13: 21–32
   PubMed Web of Science ®Google Scholar
• Nordstrom B, Levin F R. Treatment of cannabis use disorders: A review of the literature. Am J Addict. 2007; 16: 331–342
   PubMed Web of Science ®Google Scholar
• Hall S, Reus V, Munez R, et al. Cognitive behavior therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998; 55: 683–690
   PubMed Web of Science ®Google Scholar
• First M B, Spitzer R L, Gibbon M, William J BW. Structured Clinical Interview for DSM-IV Axis I Disorders—Patient Edition. Biometrics Research Department, New York State Psychiatric Institute, New York 1995, (SCID-I/P, Patient Version 2.0)
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision ed. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Kadden R, Carroll K, Donovan D, et al. Cognitive-behavioral coping skills therapy manual: A clinical research guide for therapists treating individuals with alcohol abuse and dependence. NIAAA Project Match Monograph Series. Vol. 3, National Institutes of Health, Rockville, Md 1995
   Google Scholar
• Carroll K M. A Cognitive-Behavioral Approach: Treating Cocaine Addiction. National Institutes of Health, Bethesda, Md 2000
   Google Scholar
• National Institute on Drug Abuse. NIDA Research Monograph 73. U. S. Government Print Office, Washington, DC 1986
   Google Scholar
• Guy W. ECDEU Assessment Manual for Psychopharmacology. National Institute for Mental Health, Rockville, Md 1976
   Google Scholar
• Ellis B, Johns M, Lancaster R, Raptopoulos P, Angelopoulos N, Priest R. The St. Mary's Hospital sleep questionnaire: A study of reliability. Sleep. 1981; 4: 93–97
   PubMed Web of Science ®Google Scholar
• Leigh T, Bird H, Hindmarch I, Constable P, Wright V. Factor analysis of the St. Mary's Hospital Sleep Questionnaire. Sleep. 1988; 11: 448–453
   PubMed Web of Science ®Google Scholar
• Oyefeso A, Sedgwick P, Ghodse H. Subjective sleep-wake parameters in treatment-seeking opiate addicts. Drug Alcohol Depend. 1997; 48: 9–16
   PubMed Web of Science ®Google Scholar
• McGregor C, Srisurapanont M, Jittiwutikarn J, Laobhripatr S, Wongtan T, White J. The nature, time course and severity of methamphetamine withdrawal. Addiction. 2005; 100: 1320–1329
   PubMed Web of Science ®Google Scholar
• Snaith R, Constantopoulos A, Jardine M, McGuffin P. A clinical scale for the self-assessment of irritability. Br J Psychiatry. 1978; 132: 164–171
   PubMed Web of Science ®Google Scholar
• Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959; 32: 50–55
   PubMed Web of Science ®Google Scholar
• Hamilton M. Diagnosis and rating of anxiety. Br J Psychiatry. 1969; 3: 76–79
   Google Scholar
• Kadden R M, Litt M D, Kabela-Cormier E, Petry N M. Abstinence rates following behavioral treatments for marijuana dependence. Addict Behav. 2007; 32: 1220–1236
   PubMed Web of Science ®Google Scholar
• Hawks R L, Chiang C N. Examples of specific drug assays. NIDA Res Monogr. 1986; 73: 84–112
   PubMedGoogle Scholar
• Evans S M, Levin F R, Brooks D J, Garawi F. Memantine treatment for alcohol dependence: Implementation of contingency management procedures to enhance clinical trials. Alcohol Clin Exp Res. 2007; 31: 775–782
   PubMed Web of Science ®Google Scholar